🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Samuel K. Kulp

The Ohio State University

ORCID: 0009-0003-8737-2092
Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines”.

Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines

American Journal of Veterinary Research(2008)10.2460/ajvr.69.7.938
N/A
0.515DataRank · unranked
30 citations

Sridhar Murahari, Cheryl A. London, Samuel K. Kulp, Ching-Shih Chen, William C. Kisseberth

Pharmacological strategies to target oncogenic KRAS signaling in pancreatic cancer

Pharmacological Research(2017)10.1016/j.phrs.2017.01.006
N/A
0.385DataRank · unranked
12 citations

Po-Hsien Huang, Samuel K. Kulp, Ching-Shih Chen, Hsiao-Ching Chuang

Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models

Molecular Pharmaceutics(2023)10.1021/acs.molpharmaceut.3c00069
N/A
0.241DataRank · unranked
4 citations

Jaqueline Moraes Bazioli, Herma C. Pierre, Daniel D. Lantvit, Samuel K. Kulp, Kasey Hill +7 more

Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1683
N/A
0DataRank · unranked
14 citations

Bryan Remaily, Justin Thomas, Kyeongmin Kim, Samuel K. Kulp, Thomas A. Mace +5 more

Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3724
N/A
0DataRank · unranked
33 citations

Lindsey T. Brinton, Katie Williams, Steven Sher, Shelley Orwick, Tzung-Huei Lai +21 more

Data from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition

(2023)10.1158/1078-0432.c.6531362.v1
N/A
0DataRank · unranked
0 citations

Lindsey T. Brinton, Katie Williams, Steven Sher, Shelley Orwick, Tzung-Huei Lai +21 more

Intramuscular CMT‐167 Tumours Produce a Mild Cachexia Phenotype in C57BL/6J Mice

JCSM Communications(2025)10.1002/rco2.117
N/A
0DataRank · unranked
4 citations

Trang T. Vu, Justin Thomas, Kyeongmin Kim, Camille Stanton, Zhiliang Xie +13 more

Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy

Clinical Lung Cancer(2022)10.1016/j.cllc.2021.12.010
N/A
0DataRank · unranked
44 citations

Lai Wei, Sandip H. Patel, Gabrielle Lopez, Madison Grogan, Mingjia Li +17 more

Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks

Scientific Reports(2021)10.1038/s41598-021-82252-x
N/A
0DataRank · unranked
12 citations

Riley Mullins, Jennifer M. Thomas‐Ahner, Samuel K. Kulp, Moray J. Campbell, Fabienne Lucas +8 more